Question 1

What specific benefits do you think this trial could offer me compared to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer clinical trial (NCT04799431). Contact the study team or your healthcare provider for specific answers.

Question 2

How often will I need to come in for treatments and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer clinical trial (NCT04799431). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of the neoantigen vaccine and retifanlimab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer clinical trial (NCT04799431). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer clinical trial (NCT04799431). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer clinical trial (NCT04799431). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer clinical trial (NCT04799431). Contact the study team or your healthcare provider for specific answers.

What this study is about